UOC
UBS O'Connor’s Viking Therapeutics VKTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 420 |
|
|
2024
Q4 | – | Sell |
-11,316
| Closed | -$716K | – | 512 |
|
|
2024
Q3 | $716K | Buy |
+11,316
| New | +$716K | 0.02% | 308 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 556 |
|
|
2024
Q1 | – | Sell |
-22,141
| Closed | -$412K | – | 536 |
|
|
2023
Q4 | $412K | Sell |
22,141
-35,764
| -62% | -$666K | 0.01% | 358 |
|
|
2023
Q3 | $641K | Buy |
57,905
+16,000
| +38% | +$177K | 0.01% | 360 |
|
|
2023
Q2 | $679K | Sell |
41,905
-23,703
| -36% | -$384K | 0.01% | 410 |
|
|
2023
Q1 | $1.09M | Buy |
+65,608
| New | +$1.09M | 0.03% | 388 |
|
|
2022
Q4 | – | Sell |
-247,000
| Closed | -$672K | – | 314 |
|
|
2022
Q3 | $672K | Buy |
+247,000
| New | +$672K | 0.01% | 771 |
|
|
2019
Q1 | – | Sell |
-102,842
| Closed | -$787K | – | 137 |
|
|
2018
Q4 | $787K | Buy |
102,842
+7,842
| +8% | +$60K | 0.03% | 168 |
|
|
2018
Q3 | $1.66M | Buy |
+95,000
| New | +$1.66M | 0.04% | 180 |
|